Status:
COMPLETED
Validation of B-type Natriuretic Peptide With N-terminal Pro B-type Natriuretic Peptide in Perioperative Risk Assessment
Lead Sponsor:
Jordan Leitch
Conditions:
Perioperative Care
Eligibility:
All Genders
18+ years
Brief Summary
This is a single-centre, prospective study to determine the correlation and comparative thresholds between N-terminal pro-brain natriuretic peptide (NT ProBNP, Roche) and brain natriuretic peptide (BN...
Detailed Description
This is a single-centre, prospective study to determine the correlation and comparative thresholds between NT ProBNP (Roche) and BNP (Abbott) tests. This will involve simultaneous serum sampling for b...
Eligibility Criteria
Inclusion
- Patient consents to study and is undergoing non-cardiac surgery and is one of:
- Age \> 65 years
- Revised cardiac risk index (RCRI) \>=1
- Age \> 45 years old with significant cardiovascular disease (coronary artery disease, peripheral arterial disease, cerebral vascular disease, congestive heart failure, obstructive intracardiac disease such as severe aortic stenosis, severe mitral stenosis or severe hypertrophic obstructive cardiomyopathy)
Exclusion
- Age \< 18 years
- Patient undergoing cardiac surgery
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
466 Patients enrolled
Trial Details
Trial ID
NCT05352698
Start Date
May 1 2022
End Date
August 31 2023
Last Update
June 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kingston Health Sciences Centre
Kingston, Ontario, Canada, K0H1S0